Fundraising Fox
Shape Memory Medical
San Jose, US · Delaware corporation · 50 employees on LinkedIn · 5 known investors
Find your way into Shape Memory Medical
124 people in our graph can introduce you to the Shape Memory Medical team.
Sign up to see every warm intro you have to Shape Memory Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Shape Memory Medical team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Shape Memory Medical develops embolization and occlusion medical devices built on a bioabsorbable shape memory ("smart") polymer that expands to conform to vascular anatomy. Its product portfolio includes the IMPEDE, IMPEDE-FX, IMPEDE-FX RAPIDFILL and Trellix devices for peripheral, neurovascular and aortic applications, supported by clinical trials such as AAA-SHAPE and FLAGSHIP.
Founders & leadership
EF
Edward F. Ruppel, JrExecutive
CM
Carolyn M. BrugueraExecutive
JY
James Y LancasterExecutiveJames Y Lancaster is a venture capital investor and operator with over 25 years of experience in deep tech and medical device sectors. He has founded and served as CEO of venture-backed companies including Solenic Medical, manages Innovate Angel Funds with $3M+ deployed across 42 companies, and serves as fractional executive and board director for early-stage founders.
Board
TR
Thom RascheBoard director
TT
Thomas ThalerBoard director
CK
Carla Kikken-JussenBoard director
JH
Jonathan HartmanBoard director
Investors · 5
Emergent Medical Partners, LLPlisted by Emergent Medical Partners, LLPSan Jose
How we know: Emergent Medical Partners, LLP's portfolio page · Not right? Tell us
HBM Healthcare Investmentslisted by HBM Healthcare InvestmentsZug
How we know: HBM Healthcare Investments's portfolio page · Not right? Tell us
HBM Partnerslisted by HBM PartnersZug · $5M – $50M
How we know: HBM Partners's portfolio page · Not right? Tell us
Earlybird Venture CapitalinferredBerlin · $540K – $12M
How we know: board seat on SEC Form D · Not right? Tell us
Taiwania CapitalreportedTaipei
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$81.3M disclosed across 8 rounds · 2014–2026
▶$6.9MraisedJul 2026 · 16 investors · Other Health CareRule 506(b)
▶$6.9MraisedJul 2026 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Edward F. Ruppel, JrExecutive Officer, Director
- Thomas ThalerDirector
- Michael HensonExecutive Officer, Director
- Duncan MaitlandDirector
- Thom RascheDirector
- Carolyn M. BrugueraExecutive Officer
- Offering amount
- $10M
- Amount sold
- $6.9M
- Minimum investment
- $25K
- First sale
- Jul 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$17MraisedMay 2026 · 44 investors · Other Health CareRule 506(b)
▶$17MraisedMay 2026 · 44 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thom RascheDirector
- Duncan MaitlandDirector
- Thomas ThalerDirector
- Michael HensonExecutive Officer, Director
- Edward F. Ruppel, JrExecutive Officer, Director
- Carolyn M. BrugueraExecutive Officer
- Offering amount
- $17M
- Amount sold
- $17M
- Minimum investment
- $25K
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$30.5MraisedFeb 2024 · 73 investors · Other Health CareRule 506(b)
▶$30.5MraisedFeb 2024 · 73 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Edward F. RuppelExecutive Officer, Director
- Duncan MaitlandDirector
- Thomas ThalerDirector
- Michael HensonExecutive Officer, Director
- Offering amount
- $37.8M
- Amount sold
- $30.5M
- Minimum investment
- $24.7K
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.8MraisedApr 2023 · 37 investors · Other Health CareRule 506(b)
▶$4.8MraisedApr 2023 · 37 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Edward F. RuppelExecutive Officer, Director
- Thomas ThalerDirector
- Duncan MaitlandDirector
- Michael HensonExecutive Officer, Director
- Offering amount
- $6.3M
- Amount sold
- $4.8M
- Minimum investment
- $2.8K
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.5MraisedJul 2022 · 37 investors · Other Health CareRule 506(b)
▶$11.5MraisedJul 2022 · 37 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thomas ThalerDirector
- Edward RuppelExecutive Officer, Director
- Duncan MaitlandDirector
- Michael HensonDirector
- Offering amount
- $19.5M
- Amount sold
- $11.5M
- Minimum investment
- $15.8K
- First sale
- May 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedAug 2017 · 15 investors · Other Health CareRule 506(b)
▶$7MraisedAug 2017 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Carolyn M. BrugueraExecutive Officer
- Thomas ThalerDirector
- Michael HensonDirector
- Jim GamettDirector
- Edward F. Ruppel, Jr.Executive Officer, Director
- Duncan MaitlandDirector
- Offering amount
- $14M
- Amount sold
- $7M
- Minimum investment
- $7.5K
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$3MraisedApr 2016 · 12 investors · Other Health CareRule 506(b)
▶$3MraisedApr 2016 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- James Y. LancasterExecutive Officer
- Duncan MaitlandExecutive Officer, Director
- Edward F. RuppelExecutive Officer, Director
- Michael HensonDirector
- Carla Kikken-JussenDirector
- Jonathan HartmanDirector
- Offering amount
- $4M
- Amount sold
- $3M
- Minimum investment
- $28K
- First sale
- Apr 2016
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
▶$616.5KraisedJan 2015 · 10 investors · Other Health CareRule 506(b)
▶$616.5KraisedJan 2015 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Carla Kikken-JussenDirector
- Jonathan HartmanDirector
- Duncan MaitlandExecutive Officer, Director
- James Y LancasterExecutive Officer, Director
- Offering amount
- $4.8M
- Amount sold
- $616.5K
- First sale
- Dec 2014
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Sparta BiomedicalSparta Biomedical develops chemically engineered cartilage implants built on its Hyalos hydrogel platform, including Karthyx, an MTP hemiarthroplasty device that combines the cartilage-mimicking hydrogel with a titanium fixation technology. The company targets treatment of joint cartilage degeneration and osteoarthritis through cartilage-like implants for joints such as the great toe.
Verse MedicalVerse Medical builds software to coordinate home-based healthcare services, replacing fragmented vendor interactions and outdated communication methods with a unified platform for in-home care providers.
Companies working in the same space as Shape Memory Medical.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $2.3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $199.6K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Shape Memory Medical do?
- Shape Memory Medical develops embolization and occlusion medical devices built on a bioabsorbable shape memory ("smart") polymer that expands to conform to vascular anatomy. Its product portfolio includes the IMPEDE, IMPEDE-FX, IMPEDE-FX RAPIDFILL and Trellix devices for peripheral, neurovascular and aortic applications, supported by clinical trials such as AAA-SHAPE and FLAGSHIP.
- Who founded Shape Memory Medical?
- Shape Memory Medical was founded by Duncan Maitland.
- Who are Shape Memory Medical's investors?
- Shape Memory Medical's investors include Emergent Medical Partners, LLP, HBM Healthcare Investments, HBM Partners, Earlybird Venture Capital, Taiwania Capital.
- How much funding has Shape Memory Medical raised?
- Shape Memory Medical has disclosed $81.3M raised across 8 rounds.
- Where is Shape Memory Medical headquartered?
- Shape Memory Medical is headquartered in San Jose, US.